MAPT and type 2 diabetes mellitus: For instance, in vivo T2D-associated impaired insulin and IGF-1 signaling was accompanied by neuronal loss, neurite degeneration, AβPP dysmetabolism and tau protein hyperphosphorylation (41, 42).